Literature DB >> 9201100

Predictive value of family history in diagnosis of hereditary hemochromatosis.

N Assy1, P C Adams.   

Abstract

Our objective was to study the predictive value of the family history in the initial diagnosis of hereditary hemochromatosis. Sixty five hemochromatosis proband patients and 66 control patients with chronic liver disease were assessed for a family history of hemochromatosis, cirrhosis, diabetes, and arthritis. There were no significant differences in the frequency of cirrhosis, diabetes, and arthritis between hemochromatosis patients and control patients. A family history of hemochromatosis was present in 3.6% of hemochromatosis patients and none of the control patients. Multivariate discriminative analysis demonstrated that the combination of cirrhosis, diabetes, and arthritis could only predict the diagnosis of hemochromatosis in 48% of cases. We conclude that a family history of cirrhosis, arthritis, and diabetes is not more common in hemochromatosis patients compared to control patients with chronic liver disease.

Entities:  

Mesh:

Year:  1997        PMID: 9201100     DOI: 10.1023/a:1018878813075

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  Early diagnosis and treatment of hemochromatosis.

Authors:  P C Adams; J W Halliday; L W Powell
Journal:  Adv Intern Med       Date:  1989

Review 3.  Evolving expression of hereditary hemochromatosis.

Authors:  P C Adams; L S Valberg
Journal:  Semin Liver Dis       Date:  1996-02       Impact factor: 6.115

4.  Factors affecting glucose tolerance in hereditary hemochromatosis.

Authors:  I M Hramiak; D T Finegood; P C Adams
Journal:  Clin Invest Med       Date:  1997-04       Impact factor: 0.825

5.  Hepatic iron in hemochromatosis.

Authors:  P C Adams
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

6.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study.

Authors:  J Rahier; S Loozen; R M Goebbels; M Abrahem
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

Review 7.  Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis.

Authors:  W Stremmel; C Niederau; M Berger; H K Kley; H L Krüskemper; G Strohmeyer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

8.  Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database.

Authors:  P C Adams; J C Gregor; A E Kertesz; L S Valberg
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

9.  Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.

Authors:  K M Summers; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-07       Impact factor: 17.425

10.  Long-term survival in patients with hereditary hemochromatosis.

Authors:  C Niederau; R Fischer; A Pürschel; W Stremmel; D Häussinger; G Strohmeyer
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  3 in total

1.  Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.

Authors:  Paul C Adams; Mark Speechley; James C Barton; Christine E McLaren; Gordon D McLaren; John H Eckfeldt
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

2.  Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study.

Authors:  Ronald T Acton; James C Barton; Leah V Passmore; Paul C Adams; Gordon D McLaren; Catherine Leiendecker-Foster; Mark R Speechley; Emily L Harris; Oswaldo Castro; Jacob A Reiss; Beverly M Snively; Barbara W Harrison; Christine E McLaren
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-27       Impact factor: 11.382

3.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.